Facts of the Case

Oriflame India Private Limited, engaged in the import and sale of cosmetic and personal care products, filed returns for the relevant assessment years and furnished transfer pricing documentation for its international transactions. The Transfer Pricing Officer made adjustments to the ALP by adopting Modicare Ltd. as the principal comparable.

The assessee objected on the ground that Modicare was functionally different and operated across multiple product segments, unlike Oriflame, which was focused on cosmetics. The matter reached the Income Tax Appellate Tribunal (ITAT), which acknowledged differences but still remanded the matter instead of excluding the comparable.

The Delhi High Court, in connected appeals, considered whether such remand was legally sustainable. The present appeals (ITA 812/2017, 813/2017, 825/2017) were allowed by following the reasoning in ITA 811/2017 decided on the same date.

Issues Involved

  1. Whether Modicare Ltd. was a proper comparable for transfer pricing purposes.
  2. Whether the ITAT was justified in remanding the matter while accepting functional dissimilarities.
  3. Whether adjustments could be made to remove material differences in comparables.
  4. Whether TNMM could be considered as the most appropriate method instead of RPM.

Petitioner’s Arguments (Assessee’s Contentions)

  • Modicare Ltd. was functionally incomparable due to diversified product lines.
  • Product segmentation and revenue recognition policies were materially different.
  • Discount structures, transportation, insurance, and warranty obligations materially impacted gross margins.
  • Other trading comparables suggested by the assessee were wrongly rejected.
  • Appropriate adjustments could align trading comparables better than using Modicare.

Respondent’s Arguments (Revenue’s Contentions)

  • The Revenue argued that Rule 10B permits adjustments for differences.
  • Any dissimilarity could be addressed by the Transfer Pricing Officer during remand proceedings.
  • The ITAT’s remand direction was legally justified for fresh comparability analysis.
  • The assessee could produce further supporting data before the TPO.

Court Findings / Court Order

The Delhi High Court held that:

  • If the Tribunal accepted that Modicare Ltd. was functionally dissimilar, it should have clearly dealt with exclusion instead of an incomplete remand.
  • The significant differences in product profile and operational model were vital and required proper adjudication.
  • The Revenue’s rejection of assessee’s comparables required deeper examination.
  • The matter was directed to be reconsidered with specific attention to functional comparability and adjustments.

The Court allowed the appeals and directed reconsideration of the ALP determination on proper legal parameters.

Important Clarification

This judgment clarifies that:

  • Functional comparability cannot be ignored merely by remanding the matter.
  • If a comparable is fundamentally different, it must be properly excluded or adjusted with clear reasoning.
  • Transfer pricing analysis must be aligned with statutory comparability principles under Rule 10B.
  • Selection of a single comparable without proper FAR (Functions, Assets, Risks) analysis is legally vulnerable.

Link to download the order -https://delhihighcourt.nic.in/app/case_number_pdf/2018:DHC:2331-DB/SRB10042018ITA8122017.pdf

Disclaimer

This content is shared strictly for general information and knowledge purposes only. Readers should independently verify the information from reliable sources. It is not intended to provide legal, professional, or advisory guidance. The author and the organisation disclaim all liability arising from the use of this content. The material has been prepared with the assistance of AI tools.